Integra LifeSciences Launches SurgiMend PRS Meshed Collagen Matrix for Breast Reconstruction in Europe in

October 4, 2017

Integra LifeSciences Holdings (IART) said Tuesday that, following the receipt of CE Mark approval, it is introducing its Integra SurgiMend PRS Meshed in Europe, part of the company’s expanded acellular dermal tissue matrix product line for plastic and reconstructive surgery, including breast reconstruction.

Integra SurgiMend PRS Meshed is expected to be released in Europe in October. It is an acellular dermal tissue matrix derived from bovine dermis, and is intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. It is specifically indicated for plastic and reconstructive surgery, including breast reconstruction.

The SurgiMend PRS Meshed solution offers patients the possibility for one single-stage implant breast reconstruction post-mastectomy, instead of multiple-stage surgery.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

By Stephen Holmes

Free Email Newsletter


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter: